Germany, and gave written consent to participate in the study. Registration of the study was performed internationally (European Union Drug Regulating Authorities Clinical Trials: EudraCT 2008-006135-12; International Standard Randomised Controlled Trial Number Register: ISRCTN 53154834), and ethics approval was obtained from German authorities (Bundesinstitut fü r Arzneimittel und Medizinprodukte; BfArM-Nr. 4034705) and the ethical commission (Ethikkommission des Landes Berlin; Nr. EK 12 581/08).
Haemodynamic protocol
Administration of study fluids was started intraoperatively after induction of anaesthesia and establishing haemodynamic monitoring via arterial and central venous lines and oesophageal Doppler (CardioQ TM , Deltex Medical, Chichester, UK), and finished at the end of surgery. Haemodynamic measurements were performed before and after each administration of study fluid, after every haemodynamic change of mean arterial pressure or heart rate or at least every 15 min. After an initial i.v. bolus administration of 200 ml of the study fluid, stroke volume was measured by oesophageal Doppler. If an increase in stroke volume was ,10%, study fluid administration was stopped. If there was an increase of .10%, another volume challenge with 200 ml was given until no further increase in stroke volume of ≥10% could be measured. A decrease in stroke volume by .10% compared with the stroke volume after the last volume bolus triggered another volume bolus of 200 ml of the study fluid. The algorithm was followed up to the end of surgery. In cases of haemodynamic instability or massive bleeding, bolus administration was doubled to 400 ml if the corrected flow time was below 300 ms. At the maximum dose of the study fluid (50 ml kg 21 body weight was reached), the haemodynamic algorithm was followed by transfusion of fresh-frozen plasma. The haemodynamic algorithm additionally indicated bolus administration of a vasopressor and continuous administration of norepinephrine when mean arterial pressure decreased below 70 mm Hg or the indication of a positive inotropic drug if the cardiac index remained below 2.5 litre min 
Endpoints
The primary endpoint of the study was the amount of i.v. administered study fluids used during surgery within the haemodynamic algorithm guided by oesophageal Doppler. Secondary outcome measures were doses and duration of therapy with catecholamines, length of intensive care unit stay and length of hospital stay, the rate of postoperative organ dysfunction and complications (cardiac, pulmonal, renal, gastrointestinal), and perioperative urine output and renal plasma markers creatinine and neutrophil gelatinase-associated lipocalin (NGAL). NGAL was determined with an assay kit (NGAL test TM by Bioport, Gentofte, Denmark).
Study design: planning, randomization, and recruitment
As there were no preliminary data in the literature comparing crystalloid with colloid solution within a goal-directed haemodynamic algorithm, this study was planned as a pilot study with 25 subjects per group. Subjects were randomly allocated to receive either balanced crystalloid solution (Jonosteril w , Fresenius Kabi, Bad Homburg, Germany) or balanced colloid solution (Volulyte w , Fresenius Kabi) within a haemodynamic algorithm. The random list was generated by a biostatistician and given to the Pharmacy of the University Hospital Charité. After receiving written informed consent, study participation was faxed to the pharmacy using a pseudonym with the stratification (presence or not of ascites). The pharmacy provided colour-coded study medication, which avoided identification of the study fluids to maintain blinding while being transparent to assure that i.v. air administration could safely be prevented. For emergencies, unblinded sealed envelopes were provided (Fig. 1 ).
Statistical analysis
Data were expressed according to their scaling as arithmetic mean [standard deviation (SD)], median (25%, 5% quartiles), or frequencies (%). After checking the distributions for normality, differences between groups in terms of interesting clinical parameters were tested using the non-parametric exact Mann-Whitney tests for independent groups or exact Wilcoxon tests for pairwise comparisons. Frequencies were tested by the exact Mantel-Haenszel test (ordered categories) or the exact x 2 test in contingency tables. Changes with respect to time were analysed using multivariate nonparametric analysis of longitudinal data in a two-factorial design [1st (independent) factor: groups, 2nd (dependent) factor: repetitions in time]. All time points were simultaneously compared on the corresponding response curves. The following hypotheses were tested: differences between groups (Group), systematic changes in time (over groups) (Time overall), interactions between group differences and time (Group×Time), and systematic changes in time separately for every group (Time course).
After global testing, post hoc analyses were carried out to detect specific differences with respect to groups for fixed times (Mann -Whitney tests). A two-tailed P-value of ,0.05 was considered statistically significant. Tests have to be considered as exploratory data analysis. Therefore, no adjustments for multiple testing have been made. All numerical calculations were performed with IBM& SPSS& Statistics, Version 20, Copyright 1989, 2010 SPSS Inc., and SAS, Version 9.1, Copyright SAS Institute, Inc., Cary, NC, USA.
Results
Subject data and baseline characteristics revealed no significant differences between groups (Supplementary Table S1 ). There were no differences in preoperative tumour characteristics, surgical procedures performed for cancer BJA Feldheiser et al. Table S2 ), or intraoperative data (Supplementary Table S3 ).
reduction (Supplementary
The administered volume of study fluid was significantly higher and a higher percentage of subjects reached the dose limit in the balanced crystalloid group. The median time to reaching the 50 ml kg 21 dose limit was 2 h 26 min in the crystalloid group and 3 h 33 min in the colloid group, leading to a higher percentage of subjects and higher number of units of transfusions with fresh-frozen plasma (Table 1 and Fig. 2 ). Goal-directed crystalloid and colloid therapy Analysis of intraoperative haemodynamic data showed no differences in heart rate, mean arterial and central venous pressure, or norepinephrine administration over time. This was in contrast to a significant higher stroke volume and corrected flow time in the balanced HES group (Table 2 and Fig. 3 ). Under initial preload optimization, balanced HES increased stroke volume and corrected flow time significantly better than balanced crystalloid (Supplementary Fig. S1 ).
Postoperative data (Table 3) showed no difference in the length of stay in the hospital or intensive care unit. Perioperative complications were evaluated according to the Clavien classification. 11 12 There were no differences in the highest grade, or total number of complications. Recovery of bowel function, health status EQ-5D, and activity scores showed no differences. Perioperative renal function revealed no differences between groups in intra-and postoperative urine output, perioperative creatinine, and NGAL (Fig. 4 and Supplementary Fig. S2 ). During the 3 month follow-up period, five subjects in the balanced HES group died, while no subjects died in the balanced crystalloid group (P¼0.051). Before unblinding, all deaths were assessed to be not related to the study protocol and two subjects were excluded from the analysis. One excluded subject suffered postoperative abdominal abscesses, consented therapeutic limitations during rehabilitation, and died 3 months after operation related to septic shock. The other excluded subject had a signet ring cell carcinoma and died because of tumour progression 2.5 months after operation. In two subjects, optimal tumour resection was not possible due to diffuse tumour dissemination in mesentery, intestinal, and gastric serosa, and death occurred 1.5 months and nearly 2 months after operation. The fifth subject suffered respiratory failure the day after surgery and died in progressive cardiac shock the second postoperative day. Cardiac catheterization revealed a 90% stenosis of the left main coronary artery without interventional or surgical possibilities.
Discussion
The main findings of this preliminary study are that the balanced HES group required less study fluid with longer intravascular effect and less transfusion of fresh-frozen plasma. This was associated with better haemodynamic stability, higher stroke volume, cardiac index, and corrected flow time and lower systemic vascular resistance. This study demonstrates for the first time that within a goal-directed haemodynamic algorithm, a colloid solution reduces intraoperative fluid demand and provides improved circulatory flow measured by stroke volume and cardiac output.
Perioperative fluid overload is associated with an increase in postoperative complications 4 13 and restrictive fluid therapy is beneficial in abdominal surgery. 4 14 Because of proposed higher intravascular volume effects, colloid solutions offer the possibility to improve intraoperative circulatory flow more substantially than crystalloid solutions. 15 This is associated with lower amounts of i.v. administered fluids potentially avoiding fluid overload. The beneficial intraoperative effect by the HES colloid solution in this study was not associated with a reduction in postoperative complications or reduced hospital length of stay. This could be due to the beneficial effects of administration of higher amount of fresh-frozen plasma in the crystalloid group. Studies examining haemodynamic effects of i.v. solutions found that all artificial solutions did reduce peripheral vascular resistance in limb and whole body perfusion models. 16 Only plasma seems not to alter peripheral vascular resistance and therefore could avoid further deterioration of haemodynamic stability in the postoperative course. 16 This administration of higher amounts of fresh-frozen plasma is a possible explanation for why the worse intraoperative cardiac outputs in the crystalloid group were not associated with adverse outcomes. After receiving more fresh-frozen plasma, these subjects presented less demand for volume administration during the postoperative course blunting the intraoperative beneficial haemodynamic effect of the colloid solution.
The study groups showed no differences in intraoperative heart rate, mean arterial or central venous pressure, or norepinephrine requirements. In previous studies comparing colloid with crystalloid solutions, drug administration was guided by the physician's discretion or by conventional parameters like mean arterial or central venous pressure or heart rate. 9 17-19 Our data demonstrate that future studies comparing the effects of i.v. solutions should use an administration algorithm to enable clinicians to transfer the findings into clinical practice. This is the first study of the intraoperative use of a goaldirected haemodynamic algorithm to optimize stroke volume, in which the use of balanced starch did not cause renal damage compared with balanced crystalloid solution. An initial postoperative decrease in renal function was seen in both study groups but recovered up to the third postoperative day. These data for intraoperative use are in contrast to the VISEP and the 6S Trial Group study that showed detrimental effects of starches on kidney function and an increased need for renal replacement therapy. 9 18 But in VISEP, the dose limits of starches were not observed, and in both studies, administration was guided by physician's discretion or conventional parameters, which are not suitable perioperatively for measuring changes in stroke volume or cardiac index. 6 20-22 This study shows that balanced starches used within a goal-directed haemodynamic algorithm to Goal-directed crystalloid and colloid therapy optimize stroke volume did no further harm to renal function compared with balanced crystalloid solutions perioperatively. All subjects had major surgeries, 2 3 which is reflected in the high Portsmouth POSSUM scores and the resulting predicted risk for morbidity .90% and for mortality .15%. In this context, the intrahospital mortality of 2% in this study is considered low. The mortality after 3 months was considered as not related to the study intervention before unblinding in this study. Three of the patients died because of tumour progression after being operated with a palliative approach and two were excluded before unblinding due to severe protocol violations. Nevertheless, the mortalities of 0% and 19% in the balanced crystalloid and the balanced colloid group, respectively, have to be further studied in upcoming studies.
Limitations of the study
The study was planned as a pilot study and was not powered to examine the effects of the i.v. solutions on hospital length of stay, the need for intensive care medicine, or postoperative complication rates. Larger randomized prospective trials (on the basis of the results provided here) are needed to address these questions and validate the findings of this study.
As the higher amount of administered fresh-frozen plasma could influence the balanced crystalloid group beneficially, the study cannot differentiate between possible favourable effects of balanced starches compared with balanced crystalloids or fresh-frozen plasma. Further studies are needed to compare crystalloid and colloid solutions within a goaldirected haemodynamic algorithm without interference with the effects of fresh-frozen plasma.
Summary
Within a goal-directed haemodynamic algorithm guided by oesophageal Doppler to optimize stroke volume, balanced starch solutions were associated with better haemodynamic stability, a decrease in fresh-frozen plasma units transfused, and no signs of impact on renal function. The differences in haemodynamic stability were reflected by differences in stroke volume, cardiac index, and corrected flow time. In contrast, mean arterial, central venous pressure, heart rate, and norepinephrine administration were unable to detect the changes in haemodynamic status sufficiently.
Supplementary material
Supplementary material is available at British Journal of Anaesthesia online. 
